Research Site

Taiyuan, Shanxi 030012

1 studies enrolling now · 3 studies all time

What they study most

ATTR, ATTR-CM, ATTR-Mixed, ATTRv-PN, Dyslipidemia, Heart Failure, Transthyretin Amyloidosis, hATTR

Studies at this site

• Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis — Recruiting now
• Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk — Completed
• Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection Fraction — Completed